New framework prioritizes chemicals posing blood pressure risks to children and adolescents

A new study proposes a data-driven way to identify which chemicals pose the greatest risk to children’s cardiovascular health, using elevated blood pressure as a test case. Published in npj Emerging Contaminants, the research introduces an integrative framework designed to move beyond the traditional “one chemical, one hazard” approach. Instead of evaluating substances solely on the basis of toxicity or exposure, the method combines evidence from human epidemiology, laboratory studies, exposure science, biological mechanisms and the special vulnerability of children and adolescents. The goal is to help scientists and regulators focus limited resources on chemicals most likely to contribute to preventable disease.

The framework addresses a growing public-health problem. Children are exposed to complex mixtures of substances through food, drinking water, household dust, consumer products, air pollution and contaminated environments. Many of these chemicals are present at low concentrations, but exposure can occur repeatedly and during sensitive developmental periods. At the same time, cardiovascular risk is increasingly being recognized as a condition that can begin early in life. Elevated blood pressure during childhood and adolescence is associated with an increased likelihood of hypertension, heart disease and stroke later in adulthood. Because thousands of chemicals circulate through modern environments, determining which ones deserve urgent investigation has become a major scientific challenge.

The researchers selected elevated blood pressure as a proof-of-concept outcome because it is measurable, biologically important and influenced by several pathways that may be disrupted by environmental contaminants. Blood pressure is regulated through a network involving the kidneys, blood vessels, the nervous system, hormones and immune signaling. Chemicals that interfere with renal development, alter vascular tone, promote oxidative stress, disturb endocrine function or trigger chronic inflammation could plausibly affect this network. During childhood, these systems are still developing, meaning that a chemical’s effects may differ from those observed in adults. The framework therefore treats age, developmental stage and timing of exposure as essential elements of risk prioritization rather than secondary details.

A central feature of the proposed approach is the integration of different types of evidence that are often assessed separately. Human studies can reveal associations between chemical exposure and blood pressure, but they may be limited by small sample sizes, exposure misclassification or the difficulty of accounting for chemical mixtures. Experimental studies can clarify mechanisms and dose responses, yet results from animals or cell systems do not always translate directly to children. Exposure data can show whether a substance is widespread, persistent or concentrated in particular communities, while toxicological data can indicate whether it has the capacity to damage organs or interfere with biological signaling. By placing these evidence streams into a common framework, the researchers seek to produce a more balanced estimate of concern.

The model also recognizes that risk is not determined by toxicity alone. A highly toxic substance may represent a limited population threat if exposure is rare, while a moderately toxic chemical could become a major public-health priority if children encounter it frequently through multiple routes. The framework is intended to account for both hazard and exposure, along with the strength and consistency of available evidence. It can also incorporate uncertainty, an important feature when data are incomplete. Rather than treating missing information as proof of safety, the approach can highlight chemicals for which uncertainty itself warrants additional monitoring or targeted research.

This perspective is particularly relevant to chemicals that appear in mixtures. Children are rarely exposed to only one compound at a time. A child may encounter different substances from food packaging, personal-care products, pesticides, flame retardants, industrial pollutants and contaminated dust within the same day. These exposures may share biological targets or affect the same physiological systems, creating combined effects that are difficult to detect through conventional assessments. By emphasizing pathways linked to elevated blood pressure, the framework could help identify groups of chemicals that converge on vascular function, kidney health, endocrine signaling or inflammation, even when no individual compound appears strongly associated with disease on its own.

The study’s emphasis on prioritization does not mean that the framework declares every highlighted chemical to be a proven cause of high blood pressure. Prioritization is an early step in the scientific and regulatory process. It identifies substances that merit more intensive investigation, improved exposure measurements, stronger epidemiological studies or preventive action. The distinction is important because associations in observational studies cannot automatically establish causation. Children’s blood pressure can also be influenced by genetics, diet, physical activity, body composition, stress, socioeconomic conditions and access to healthcare. A robust framework must therefore place chemical evidence within the wider context of these factors and clearly communicate confidence levels.

The authors present the method as adaptable beyond cardiovascular health. The same architecture could potentially be used to prioritize chemicals associated with neurodevelopment, respiratory disease, metabolic disorders, immune dysfunction or reproductive effects. Its broader significance lies in connecting environmental exposure science with disease prevention. Regulators could use such tools to decide which substances require biomonitoring or stricter controls, while public-health researchers could use them to design studies around the most plausible hazards. The approach may also support more efficient testing by directing laboratory experiments toward chemicals with the greatest combination of exposure potential, biological plausibility and population vulnerability.

For families, the findings do not translate into a single new warning about one product or one contaminant. Instead, they point to a shift in how environmental risks should be investigated: earlier, more systematically and with children at the center of the analysis. Elevated blood pressure is often silent, and chemical exposures may also be invisible, making both difficult to recognize without surveillance. The framework described by Li, Wang, Zhang and colleagues offers a way to connect those hidden risks and identify where evidence can have the greatest impact. As chemical production and environmental complexity continue to grow, prioritization tools of this kind could help science and policy move faster than the next generation of preventable disease.